Chokkalingam A. Risk of total non-hepatic cancer following treatment for HCV infection with direct-acting antiviral agents. PS-155.
Benralizumab, dupilumab of mepolizumab: lagere SARS-CoV-2-immuniteit na vaccinatie
okt 2024 | Astma, Eczeem, Vaccinatie, Virale infecties